10x Genomics, Inc.
SEC 8-K · Filed
0001770787-24-000007Accepted
Applies to the EDGAR acceptance time.
Other time zone
Leadership changesItem 5.02Effective date Feb 1, 2024
James Wilbur — announced departure from the Chief Commercial Officer role
Dr. Wilbur will depart the Company on February 1, 2024
Structured facts
{
"action": "departed",
"evidence": "Dr. Wilbur will depart the Company on February 1, 2024",
"identity_source": "https://www.sec.gov/Archives/edgar/data/1770787/000161071723000367/0001610717-23-000367-index.htm",
"person": "James Wilbur",
"person_cik": "0001940931",
"role": "Chief Commercial Officer",
"state": "announced"
}